Fruquintinib Combined With Adebrelimab and High and Low Dose Radiotherapy in the Treatment of Second-line and Above Failure MSS Metastatic Colorectal Cancer.

NCT06613113 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

MSS Metastatic Colorectal Cancer

Interventions

DRUG: Fruquintinib

Sponsor

Ningbo Medical Center Lihuili Hospital

Collaborators

[object Object]